Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone604-248-4138
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.75 million
Profitability
Miscellaneous
Employees98
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
Neovasc (NASDAQ:NVCN) Frequently Asked Questions
What is Neovasc's stock symbol?
Neovasc trades on the NASDAQ under the ticker symbol "NVCN."
When did Neovasc's stock split? How did Neovasc's stock split work?
Neovasc shares reverse split before market open on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.
How were Neovasc's earnings last quarter?
Neovasc Inc (NASDAQ:NVCN) posted its quarterly earnings data on Wednesday, August, 7th. The medical equipment provider reported ($1.17) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($1.70) by $0.53. The medical equipment provider had revenue of $0.44 million for the quarter, compared to analysts' expectations of $0.60 million. View Neovasc's Earnings History.
When is Neovasc's next earnings date?
Has Neovasc been receiving favorable news coverage?
News headlines about NVCN stock have been trending somewhat positive this week, according to InfoTrie. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Neovasc earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Neovasc.
Are investors shorting Neovasc?
Neovasc saw a decline in short interest in September. As of September 30th, there was short interest totalling 153,800 shares, a decline of 9.1% from the August 30th total of 169,200 shares. Based on an average daily trading volume, of 103,400 shares, the days-to-cover ratio is currently 1.5 days. Currently, 2.2% of the company's shares are short sold. View Neovasc's Current Options Chain.
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include BRAINSWAY LTD/S (BWAY), Sensus Healthcare (SRTS), Liquidia Technologies (LQDA), Spectral Medical (EDTXF), Nephros (NEPH), Endologix (ELGX), Apollo Endosurgery (APEN), STRATA Skin Sciences (SSKN), Pro-Dex (PDEX), AIT Therapeutics (AITB), BeyondAirInc . (XAIR), Motus GI (MOTS), Nephros (NEPHD), Invo Bioscience (IVOB) and SANUWAVE Health (SNWV).
What other stocks do shareholders of Neovasc own?
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Mr. Fredericus A. Colen, Pres & CEO (Age 66)
- Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)
How do I buy shares of Neovasc?
Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Neovasc's stock price today?
One share of NVCN stock can currently be purchased for approximately $3.74.
How big of a company is Neovasc?
Neovasc has a market capitalization of $27.98 million and generates $1.75 million in revenue each year. The medical equipment provider earns $-108,040,000.00 in net income (profit) each year or ($27.30) on an earnings per share basis. Neovasc employs 98 workers across the globe.View Additional Information About Neovasc.
What is Neovasc's official website?
How can I contact Neovasc?
Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V2J7. The medical equipment provider can be reached via phone at 604-248-4138 or via email at [email protected]
MarketBeat Community Rating for Neovasc (NASDAQ NVCN)
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.
